AstraZeneca is seeking FDA approval to market Seroquel XR for treating depression and anxiety.
阿斯利康正在征求FDA批准奎硫平缓释片用于治疗抑郁症和焦虑症。
Seroquel XR is an extended release version of the medicine with a longer patent life than the original formulation.
奎硫平缓释片是该药的一个延长释放的版本。 它比奎硫平有更长的专利寿命。
Guidance is also provided on safe administration of SEROQUEL XR, including consideration of the safety profile with respect to the individual patient's diagnosis and the dose being administered.
对安全服用富马酸喹硫平也提供了安全指导,包括对个体病人的诊断和服用的剂量的安全性考虑。
应用推荐